Every quarter in 2024 was better than the last. M&A ended the year on a strong, positive note, with the industrials and TMT ...
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
12h
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for Japan's drug ...
Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results